Steris (STE) FCF Payout Ratio (QoQ) (2018 - 2026)
Steris (STE) FCF Payout Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.87% |
| Mar 31, 2026 | 267.60% |
| Dec 31, 2025 | -290.23% |
| Sep 30, 2025 | 78.59% |
| Jun 30, 2025 | 120.21% |
| Mar 31, 2025 | -469.31% |
| Dec 31, 2024 | -38.98% |
| Sep 30, 2024 | 43.89% |
| Jun 30, 2024 | -78.43% |
| Mar 31, 2024 | 318.15% |
| Dec 31, 2023 | -168.28% |
| Sep 30, 2023 | 277.94% |
| Dec 31, 2022 | -135.14% |
| Sep 30, 2022 | 500.73% |
| Jun 30, 2022 | 130.76% |
| Mar 31, 2022 | -558.11% |
| Dec 31, 2021 | -42.10% |
| Sep 30, 2021 | -45.30% |
| Jun 30, 2021 | 198.54% |
| Mar 31, 2021 | -475.99% |